Lauer Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-48,218
Closed -$694K 67
2025
Q2
$694K Buy
+48,218
New +$1.06M 0.57% 22

Other funds holding ARKG

Lauer Wealth's ARKG Position: Q2 2026 in Review

Lauer Wealth reduced its ARK Genomic Revolution ETF (ARKG) stake by 22% in Q2 2026, selling an estimated $159K and leaving 17,643 shares worth $724K. The position accounts for 0.43% of the portfolio, ranked #34.

Lauer Wealth first reported a position in ARKG in Q1 2025 and has held it in 5 quarters since. The position peaked at $730K in Q3 2025. 71 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Lauer Wealth held 17,643 shares of ARK Genomic Revolution ETF worth $724K as of Q2 2026.
  • Lauer Wealth sold 5,000 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $159K.
  • ARK Genomic Revolution ETF made up 0.43% of Lauer Wealth's portfolio in Q2 2026, its #34 holding.
  • Lauer Wealth first reported a position in ARK Genomic Revolution ETF in Q1 2025 and has held it in 5 quarters since.
  • Lauer Wealth's ARK Genomic Revolution ETF position peaked at $730K in Q3 2025.
  • 71 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Lauer Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.